Purpose
Endovascular treatment of peripheral arterial disease (PAD) is well established but remains a rapidly developing field. In spite of recent therapeutic advances with primary stenting of superficial femoral arteries [1, 2] our understanding of the mechanisms of restenosis and reocclusion of the superficial femoral artery after pecutaneous transluminal angioplasty (PTA) is incomplete. Several factors affect the patency of the femoropopliteal arterial segment after technically successful PTA, including the clinical severity of PAD, patient comorbidities such as diabetes or renal failure, morphological characteristics of the arterial lesions, i.e., occlusion vs. stenosis, length of the lesion, number of lesions, calcification of plaques [3, 4, 5, 6] , functional characteristics of the affected artery, i.e., the extent of vascular inflammation, as well as haemodynamic conditions that are to a large extent defined by the arterial »run-off« [5] .
The STAR registry and several older studies listed poor tibial run-off as strongly predictive of bad long-term patency [5, 7, 8, 9, 10, 11] , but Gordon and co-authors reported no association of femoral artery patency with tibial run-off one year after recanalization [12] .
In order to better understand the influence of infrapopliteal run-off on femoropopliteal patency after PTA, we tested: (a) whether postprocedural infrapopliteal run-off affected the rate of femoropliteal restenosis or reocclusion 1, 6 and 12 months after femoropopliteal PTA, and (b) whether worsening of infrapopliteal run-off in the year after PTA affected the long term patency of the femoropopliteal arterial segment.
Methods and Materials
At enrolment, we determined patient risk factors for PAD (Table 1 ) and the clinical stage of PAD by the Fontaine classification [3] (Table 2 ). The appropriateness of the femoropopliteal lesions for treatment by PTA was evaluated according to the TASC II classification [4] (Table 3) . Ankle-brachial indices (ABI) were measured routinely before and after PTA [13] .
All PTA procedures were performed in an interventional angiography suite by interventional radiologists. The ipsilateral anterograde approach via the common femoral artery was used except in cases of ostial lesions of the SFA, where the contralateral or transpopliteal approach was used, introducing 5 Fr sheaths for vascular access. All patients, already treated with low-dose aspirin, received local anesthesia and 5000 IU heparin i.v. at the beginning of the procedure. Most stenotic lesions were crossed by a soft 0.035-inch J-wire (Terumo Medical Corp., Somerset, NJ, USA) and in the majority of cases occlusions were crossed by the direct recanalization technique. Alternatively, the subintimal approach was used in cases of unsuccessful direct recanalization. Noncompliant balloons of 5 or 6 mm diameter from different manufacturers were used, depending on the vessel diameter in the adjacent non-diseased parts. The balloons were inflated for at least 1 minute at 8 atm pressure. Stents (nitinol self-expanding stents) were implanted only in cases of flow-limiting dissections or residual stenosis of > 50% even after repeated balloon inflation. In patients with accessible concomitant infrapopliteal lesions, PTA of the calf arteries was also performed. For infrapopliteal lesions, 0.025-inch J-Terumo wire or 0.014/0.018-inch (Pointer, Denmark; Invatec, Italy) wires were used for intraluminal crossing, with balloon diameters from 2 to 3.5 mm (different manufacturers). All angiographies were performed by the standard digital subtraction technique. The technical success of PTA and the infrapopliteal run-off were evaluated by periprocedural angiography. Immediate technical success was defined as # 50% residual angiographic stenosis [1] . PTA technique is shown on Fig. 1 Table 3 . TASC II classification of arterial lesions subjected to PTA and the site of PTA. According to the TASC II classification, endovascular treatment is preferred for category B lesions, while surgery is generally preferred for category C lesions. In deciding on the type of treatment, patient co-morbidities, patient preferences and the operators' long-term success rates must be taken into account [6] .
Infrapopliteal run-off was scored by a modification of the Society for Vascular Surgery criteria, originally intended for quantifying bypass run-off, where a higher score implies worse run-off [14] .
This scoring system ascribes 3 points for occlusion throughout the vessel, 2.5 points for occlusion of less than half of the arterial length, 2 points for maximal stenosis of 50-99 %, 1 point for maximal stenosis of 20-49%, and 0 points for less than 20 % maximal stenosis. Each of the calf arteries is ascribed a weight, i.e., multiplication factor, of 1 and the distal popliteal artery is ascribed a weight of 3, with one point always added to the total score [14] . Thus, the cumulative score for the distal popliteal artery (a maximum of 9+1) and for the tibial vessels (a maximum of 3 x 3) gives a maximum score of 19 [15] . We divided our patients' limbs into two categories: good run-off (< 5 points) and compromised run-off, the latter group consisting of a majority of limbs with a score of 5-10 points (i.e., compromised run-off) and a few limbs with a score of > 11 points (i.e., bad run-off). In the good run-off group, a limb had to have a patent popliteal artery and at least two patent calf arteries with less than 50% maximal stenosis. An occlusion of one calf artery (3 points) and more than 50 % stenosis in another calf artery (2.5 points) already implied compromised run-off. There were only 6 limbs with bad run-off, since a score of # 11 points after femoropopliteal PTA implied complete occlusion of all 3 calf arteries plus at least 20-49 % residual stenosis of the popliteal artery. Some typical examples of infrapopliteal run-off scoring are shown in Fig. 3 , 4. All subjects were examined by vascular US at 1 month (range 29 days-2 months), 6 months (range 6-8 months) and 12 months (range 12-16 months) after PTA to evaluate the development of restenosis/reocclusion of the femoropoliteal arterial segment. The US examinations were performed by ultrasonographers who were unaware of the exact site of the PTA and who recorded flow and morphology along the whole femoropopliteal arterial segment with emphasis on identifying hemodynamically significant stenoses or occlusions. The US investigations were performed on a Vivid 3 ultrasound machine (GE Medical Systems, USA) with a linear vascular probe (Vascular 10L). An adverse outcome of PTA was defined as identification of femoropopliteal stenosis of # 50 %, confirmed by at least doubling of the maximal systolic velocity in comparison to a proximal nondiseased arterial segment, or by identifying a reocclusion confirmed by the absence of a Doppler flow signal [16] . The patency of calf arteries was assessed by US at the third follow-up examination 12 months after femoropopliteal PTA [16] , and compared to the periprocedural angiographic result. During US of the calf arteries, attempts were made at visualizing as much as possible of the whole length of the two tibial arteries and the peroneal artery, i.e. interosseal artery. As in the femoropopoliteal segment, a stenosis of # 50 % was diagnosed by at least doubling of the maximal systolic velocity in comparision to a proximal non-diseased segment, whereas an occlusion was documented in the absence of Doppler flow signal. In addition, the Doppler waveform at the level of the ankle in each of the 3 calf arteries was compared to the wavwform in the tibioperoneal trunk. A change from triphasic to monophasic signal with marked reduction in peak systolic velocity and a decrease in the slope of systolic upstroke, or absence of distal flow were taken as additional evidence of significantly compromised arterial flow [16] .
Statistical analysis
Descriptive statistics was calculated for demographic data, including cardiovascular risk factors and adverse events, chronic renal insufficiency and classification of disease severity. The differences in baseline characteristics between the groups with good and compromised infrapopliteal run-off were analysed by Student's t-test for continuous variables or by the # -square test for categorical variables. Preprocedural and postprocedural ABI were compared by the t-test for paired samples in order to evaluate the immediate haemodynamic success of PTA.
The group summaries for combined restenosis/reocclusion rates and infrapopliteal runoff at 1, 6 and 12 months in the treated limbs are reported in contingency tables. The associations between adverse outcomes and run-off were tested using the #-square test. Data for reocclusions only were also tested by the #-square test at 6 and 12 months and by the Fisher exact test at 1 month since the number of adverse events was too low for the #-square test (<5 events). The difference between initial post-procedural run-off and run-off after 12 months was tested by McNemar's test. All calculations were done on level of patients with each subject classified only once-according to the more affected leg-even though 24 subjects had both legs treated with PTA.
In order to evaluate the utility of infrapopliteal PTA, we also tested the association between the femoropopliteal restenosis/reocclusion rate and pre-procedural run-off by the # -square test. 
Results
Among the technically successful femoropopliteal PTAs in 176 patients, femoral selfexpanding stents were implanted in only 3 limbs for bail-out indications. Accompanying infrapopliteal PTA was attempted in 79 (45%) patient's limbs with technical success in 70 patients's limbs (89 % technical success rate), resulting in an improved postprocedural run-off (Table 4 ). The combined complication rate of the PTAs was 7 %: 3 minor haeamatomas, 2 pseudoaneurysms (managed by conservative treatment), 1 periprocedural thrombosis (managed by successful aspiration). The average ABI improved from 0.60 ± 0.41 before PTA to 0.82 ± 0.25 after PTA (p< 0.001). 
Run-off

Amputations and mortality
Among the 176 treated patients, 3 had minor limb amputations within 1 month after PTA (2 transmetatarsal and 1 toe amputation), 4 additional patients had limb amputations within 6 months (2 above the knee and 2 below the knee), and 5 additional patients within 12 months (2 above the knee, 2 below the knee, and 1 with an undisclosed level of amputation). Overall, the amputation rate was 12/176 patients (7 %) after 1 year.
Compromised infrapopliteal run-off was documented in 8/12 (67 %) limbs of amputees treated by PTA and in 87/188 (46 %) of treated limbs that were viable, p = 0.17. Two patients died within 6 months after PTA and a total of 8/176 patients (5 %) died within the first year. Compromised infrapopliteal run-off was documented in 6/8 (75 %) of deceased patients and in 77/168 (46%) of survivors, p = 0.11.
Outcome of femoropopliteal PTA with respect to post-procedural infrapopliteal run-off
One month after PTA all 176 treated patients completed the scheduled US follow-up, 163 patients were re-examined by US after 6-8 months, and 146 patients after 12-16 months.
The patients who did not attend the scheduled follow up examinations at 6 and 12 months were excluded from further analysis under the assumption that their cause of death or other reason for missing the appointment was unrelated to the infrapopliteal run-off.
1.
The overall incidence of restenosis/reocclusion at follow-up with respect to postprocedural run-off at is shown in Table 5 .
Our calculations taking into account only those patients who completed all 3 scheduled follow-ups were very similar (data not shown) and the interpretation remained the same.
2.
In the subgroup of the patients with Fontaine stages III and IV, i.e., critical limb ischemia, who comprised the majority of our patients, the results were similar as overall: a significant difference in the combined incidence of resrenosis or reocclusion after 1 month between patients with good post-procedural run-off and those with compromised run-off, i.e., 4/46 (6%) vs. 17/69 (25%), p=0.004, while there were no significant differences at 6 and 12 months: 20/55 (36%) vs. 31/66 (45%), p=0.27, and 24/46 (52%) vs. 34/62 (55%), p=0.78.
3.
In Fontaine stage II, i.e., claudicants, who were a relatively small subgroup among our patients, we found no significant difference in the rate of restenosis/reocclusion with respect to post-procedural run-off: after 1 month 5/28 (18%) restenosis/reocclusion among patients with good run-off vs. 1/12 (8%)among patients with compromised run-off, p=0.39, after 6 months 15/28 (54%), vs 7/12 (58%), p=0.78, and after 12 months 13/26 (50%), vs. 7/10 (70), p=0.28. 
Outcome of femoropopliteal PTA with respect to pre-procedural infrapopliteal runoff
When pre-procedural run-off was taken into account, it was not associated with combined rate of restenosis/ reocclusion at any time. Pre-procedural run-off status was not associated with the outcome of PTA after one year. We find these results to be due to the improvement of tibial run-off by PTA. • These findings together, can lead us to a conclusion that improvement of tibial run-off by PTA of calf arteries prolongs the time to restenosis/ reocclusion of SFA, which is especially beneficial for patients with chronic critical ischemia. 
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